Santarus introduces Cycloset in US market

November 16th, 2010Posted by admin

Santarus has launched Cycloset (bromocriptine mesylate) tablets, approved by the US Food and Drug Administration (FDA) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus both as monotherapy and in combination with other oral antidiabetic agents, in the US. In 2009, bromocriptine mesylate was approved by [...]

Eisai Halaven receives FDA nod

November 16th, 2010Posted by admin

Halaven receives FDA approval Eisai’s new anticancer agent Halaven (generic name: eribulin mesylate) injection has received approval from the US Food and Drug Administration (FDA) for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease. Eribulin has been previously known as [...]

AstraZeneca, BMS Kombiglyze XR gets FDA nod

November 14th, 2010Posted by admin

AstraZeneca, BMS Kombiglyze XR gets FDA nod. AstraZeneca and Bristol-Myers Squibb Company’s (BMS) Kombiglyze XR has received approval from the US Food and Drug Administration (FDA) for the treatment of type 2 diabetes in adults. COMP issues positive opinion on Celsion ThermoDox ODD application The Committee for Orphan Medicinal Products (COMP) of the European Medicines [...]

US Pharmacy Online: Brands vs. Generics

November 13th, 2010Posted by admin

US Pharmacy Online: Brands vs. Generics (Advertisement) Why US Pharmacy? Getting US drugs from your online pharmacy is safe and easy. Your safety always comes first. The US Pharmacy Online is an online pharmacy providing discount prescription medication (Rx) filled for you by our licensed pharmacies. When ordering from The US-pharmacy-online.com, you will receive generic [...]

Oligomerix gets SBIR Phase II grant to discover alzheimer’s drugs

November 12th, 2010Posted by admin

Oligomerix gets SBIR Phase II grant to discover alzheimer’s drugs Oligomerix has got a two-year Small Business Innovation Research (SBIR) Phase II grant for $1.6m from the National Institute on Aging, National Institutes of Health (NIH), for a program to discover small molecules and antibodies targeting tau protein oligomers in the development of disease modifying [...]

Evergreening Strategy

November 10th, 2010Posted by admin

Evergreening of patents refers to increasing the life of the patent or the patent term beyond 20 years to reap the benefits for much longer period of time. When the original patent over the active component of a brand name drug is about to expire, these drug companies often claim large numbers of complex and [...]

Indian generics dominate the ARV market – research says

November 10th, 2010Posted by admin

Indian generic producers supply the majority of ARVs (antiretrovirals) in developing countries, a research based on utilized transactional data containing 17,646 donor-funded purchases of ARV tablets made by 115 low- and middle-income countries from 2003 to 2008 to measure market share, purchase trends and prices of Indian-produced generic ARVs compared with those of non-Indian generic [...]

NitroMist oral spray

November 8th, 2010Posted by admin

NitroMist Oral Spray NitroMist is NovaDel’s oral spray formulation of nitroglycerin, which has been approved by the FDA for acute relief of an attack of angina pectoris, or acute prophylaxis of angina pectoris, due to coronary artery disease. Nitroglycerin is also used medically as a vasodilator to treat heart conditions, such as angina and chronic [...]

Ectoin Inhalation Solution

November 8th, 2010Posted by admin

Ectoin Inhalation Solution has already shown therapeutic efficacy in the treatment of mild asthma in humans and in animal models of nanoparticle-induced inflammatory reaction in the lungs, allergen induced asthma. Bitop Medical Device Development head Andreas Bilstein said that Ectoin-containing medical devices have already shown very positive effects in different diseases. “We hope that we [...]

AstraZeneca, BMS Kombiglyze XR gets FDA nod

November 8th, 2010Posted by admin

AstraZeneca, BMS Kombiglyze XR gets FDA nod AstraZeneca and Bristol-Myers Squibb Company’s (BMS) Kombiglyze XR has received approval from the US Food and Drug Administration (FDA) for the treatment of type 2 diabetes in adults. Eisai to introduce Crystal Veil Cool Eisai is set to introduce Crystal Veil Cool, a new soothing menthol version of [...]